News

DermaRite® Industries is launching a new product to our full line of wound care products. SilvaKollagen® Gel, “Smart Silver”™, is a natural, safe and effective medical hydrolystate of Collagen with Silver.

Washington, Nov. 6 -- A new study published in Veterinary Microbiology found methicillin-resistant Staphylococcus aureus (MRSA) prevalent in Canadian pig farms and pig farmers, pointing to animal agriculture as a source of the deadly bacteria.

Organogenesis, Inc., the world's leading regenerative medicine company, announced today that Apligraf®, its living bi-layered cell therapy product used to treat non-healing wounds, has gained Swiss reimbursement, beginning August 1.

Derma Sciences, Inc., a provider of advanced wound care products, announced that on the CBS Evening News on Thursday, July 31, its key product MEDIHONEY was featured as part of a story about a specialty burn clinic in Iraq run by US National Guard volunteers. The dressing is used as standard first-line therapy in place of the traditional silvadene antimicrobial cream at the Smith Gate Burn Clinic, the only service in Iraq offering burn care to children.

Canica Design Inc. has been awarded its first U.S. patent in a series of comprehensive U.S. and international patents that dramatically advance the management and closure of wounds of all kinds.

The extensive multi-national patent portfolio covers Canica's clinical and surgical system and method for moving and stretching skin and muscle.

In a first-of-its-kind collaboration, Wound Care Education Institute (WCEI) is proud to be a partner with the Wisconsin Department of Health and Family Services, Wisconsin Health Care Association, Wisconsin Association of Homes and Services for the Aging, Wisconsin Directors of Nursing Council, National Alliance of Wound Care(R), West Bend Mutual Insurance, Golden Living, Metastar, Kindred Health Care Foundation and GuideOne Insurance, in a statewide initiative directed at educating registered nurses working in long-term care facilities in the prevention and treatment of pressure ulcers (also known as bedsores).

Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc. (formerly MB Software Corporation) announced today that it will begin an evidence based study evaluating the clinical performance of their advanced wound care collagen product, CellerateRx® on skin tears.

PharmaSurgics is developing a novel pharmaceutical product for the prevention of post-surgical adhesions, based on the human protein lactoferrin. Adhesions are bands of harmful scar tissue that develop after all types of surgical procedures and cause symptoms such as chronic pain, bowel obstruction, infertility and impaired mobility.

May 27, 2008

Reducing external pressure has long been the focus of etiological research on the prevention of skin breakdown, yet medical literature continues to reveal the important role of shear and friction in the development of skin breakdown.